Full-Time

Associate Account Manager

Confirmed live in the last 24 hours

Schrödinger

Schrödinger

501-1,000 employees

Computational platform for drug discovery research

Enterprise Software
Biotechnology
Healthcare

Entry, Junior

Cambridge, MA, USA

Category
Customer Success Management
Sales & Account Management
Required Skills
Salesforce
Requirements
  • Bachelor’s degree in Chemistry, Biology, or a related science
  • One to two years of relevant work experience, software sales experience preferred
Responsibilities
  • Manage all team engagements with assigned accounts to ensure objectives are met
  • Develop and maintain exceptional account relationships through effective communication, education, reporting and problem-solving
  • Provide feedback from clients to the internal Product Managers and Support teams
  • Support Account Management team with prospecting, lead qualification and quote generation
  • Use Salesforce CRM to track account activities and progress
  • Work with marketing to implement and coordinate prospecting campaigns

Schrödinger provides a computational platform that aids in the research efforts of biopharmaceutical companies, academic institutions, and government laboratories around the world. Their platform offers advanced computational tools that help in drug discovery and development across various therapeutic areas. Schrödinger's products work by utilizing sophisticated algorithms and simulations to predict how different compounds will interact, which can significantly speed up the research process. Unlike many competitors, Schrödinger not only licenses its software but also engages in collaborative drug discovery programs, allowing them to work closely with clients on specific projects. The company's goal is to enhance scientific research and innovation by providing powerful tools and resources that support the development of new therapies.

Company Stage

IPO

Total Funding

$362.7M

Headquarters

New York City, New York

Founded

1990

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • Schrödinger received a $10M grant to expand predictive toxicology tools.
  • The discovery of SGR-1505 showcases Schrödinger's platform efficiency in drug discovery.
  • Schrödinger's focus on ESG matters enhances corporate reputation and stakeholder trust.

What critics are saying

  • Increased competition from Recursion and Exscientia merger in AI drug discovery.
  • Avicenna's ML-enhanced platform could outpace Schrödinger's capabilities.
  • High cost and complexity of drug discovery could strain Schrödinger's resources.

What makes Schrödinger unique

  • Schrödinger's platform supports diverse clients, including biopharmaceutical companies and academic institutions.
  • The company engages in both wholly-owned and collaborative drug discovery programs.
  • Schrödinger's computational tools are used in over 70 countries worldwide.

Help us improve and share your feedback! Did you find this helpful?